Fundraising Fox

Bexorg

New Haven, US · Founded 2021 · 47 employees on LinkedIn · 7 known investors

Bexorg is a biotech platform for CNS drug discovery built on a whole-brain perfusion model that allows manipulation and recording of cellular activity in intact human brains. The company serves pharmaceutical researchers developing treatments for brain diseases.

AI & Machine LearningBiotechDigital HealthMedical Devices

Founders & leadership

Board

ZVZvonimir Vrselja
Zvonimir VrseljainFounder, Bexorg at Amplify Partners
NSNenad Sestan
Nenad SestanFounder, Bexorg at Amplify Partners

Investors · 7

Amplify PartnersMenlo Park · $500K – $5M
Connecticut InnovationsNew Haven · $500K – $2M
The Engine VenturesCambridge
Amplify Partners CVreportedMenlo Park
E1 Venturesreported · 2 sourcesSan Franciscovia Ana Levine · inferred

Also in the syndicate · 2

Engine VenturesleadStarbloom Capital

Funding

SEC filings, press & company announcements

Source: company announcements and press reports — follow each round's link for the claim.

Competitors · 1

by search overlap
Bioworld8 shared keywordsBioWorld is a suite of daily news and data services covering therapeutics, medical technology, biopharma business transactions, and drug R&D, serving biopharmaceutical and medtech industry professionals. Owned by Clarivate, it publishes products including BioWorld, BioWorld Science, and BioWorld Asia with reporting from writers stationed globally.

Companies competing with Bexorg for the same Google search keywords, organic and paid, via search-intersection analysis.

In the news

Bexorg Completes $23M Series A Bringing Total Funding to $42.5Morrick.com · Oct 2025Bexorg Raises $42.5M to Transform CNS Drug Development with World’s First Integrated AI and Whole-Human Brain Platformglobenewswire.com · Oct 2025Neuroscience start-up Bexorg nets $42.5 millioncen.acs.org · Oct 2025Bexorg Raises $42.5 Million Led by Engine Ventures to Advance AI and Whole-Human Brain Platform for CNS Drug Discovery | citybizcitybiz.co · Oct 2025Bexorg raises $23M to test drugs on ‘rebooted’ human brains from organ donorsendpoints.news · Oct 2025

Frequently asked questions

What does Bexorg do?
Bexorg is a biotech platform for CNS drug discovery built on a whole-brain perfusion model that allows manipulation and recording of cellular activity in intact human brains. The company serves pharmaceutical researchers developing treatments for brain diseases.
Who are Bexorg's investors?
Bexorg's investors include Amplify Partners, Connecticut Innovations, The Engine Ventures, Amplify Partners CV, E1 Ventures.
Where is Bexorg headquartered?
Bexorg is headquartered in New Haven, US.